MarketPulse

seizure reduction

2 articles
BenzingaBenzinga··Vandana Singh

Praxis Precision Surges on FDA Nod for Essential Tremor Treatment

Praxis Precision shares surge 7.15% after FDA accepts essential tremor drug application with January 2027 decision target and positive Phase 3 results.
PRAXFDA approvalbiotech
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Praxis Precision Medicines Posts Breakthrough Results for Rare Epilepsy Gene Therapy

Praxis reports 77% placebo-adjusted seizure reduction in SCN2A epilepsy treatment with no serious safety events, advancing precision neurotherapy.
PRAXIONSclinical trialprecision medicine